Budget Amount *help |
¥4,160,000 (Direct Cost: ¥3,200,000、Indirect Cost: ¥960,000)
Fiscal Year 2012: ¥2,340,000 (Direct Cost: ¥1,800,000、Indirect Cost: ¥540,000)
Fiscal Year 2011: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
|
Research Abstract |
Drug delivery system (DDS), which is for delivery of anticancer drugs to cancer tissue, is very important because it enhances the therapeutic effects and reduces the side effects. The aim of this study is development of a DDS using hydroxyapatite as a nanoparticle carrier. A novel cancer diagnosis and therapy DDS, which is a conjugation between a radiolabeled compound with high bone affinity and hydroxyapatite, was synthesized and evaluated.
|